Gene therapy for ocular disease

Molecular Therapy

Volumn 1, Issue 6, 2000, Pages 501-505

  Bennett, Jean ^a   Maguire, Albert M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL; CORNEA DISEASE; EYE DISEASE; EYE TUMOR; GENE THERAPY; GENE VECTOR; GENETICS; GLAUCOMA; HUMAN; METHODOLOGY; MUTATION; RETINA DEGENERATION; RETINOBLASTOMA; REVIEW; VITREORETINOPATHY;

ANIMALS; CORNEAL DISEASES; EYE DISEASES; EYE NEOPLASMS; GENE THERAPY; GENETIC VECTORS; GLAUCOMA; HUMANS; MUTATION; NERVE GROWTH FACTORS; RETINAL DEGENERATION; RETINOBLASTOMA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0034200932     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0080     Document Type: Review

References (55)

1. Wenkel, H., and Streilein, J. W. (1998). Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest. Ophthalmol. Vis. Sci. 39: 1823-1834.
2. Streilein, J. (1995). Enhanced perspective: Unraveling immune privilege. Science 270: 1158.
3. Wilbanks, G. A., and Streilein, J. W. (1991). Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol. 146: 2610-2617.
4. Wilson, S. E., Schultz, G. S., Chegini, N., Weng, J., and He, Y. (1994). Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp. Eye Res. 59: 63-71.
5. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., and Ferguson, T. A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
6. Bennett, J., Wilson, J., Sun, D., Forbes, B., and Maguire, A. (1994). Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthatmot. Vis. Sci. 35: 2535-2542.
7. Li, T., et al. (1994). In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 35: 2543-2549.
8. Bennett, J., Duan, D., Engelhardt, J., and Maguire, A. M. (1997). Real-time non-invasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38: 2857-2863.
9. Grant, C., Ponnazhagan, S., Wang, X.-S., Srivastava, A., and Li, T. (1997). Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Curr. Eye Res. 16: 949-956.
10. Flannery, J., et al. (1997). Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94: 6916-6921.
11. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotech. 15: 871-875.
12. Miyoshi, H., Takahashi, M., Gage, F., and Verma, I. (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natt. Acad. Sci. USA 94: 10319-10323.
13. Bennett, J., and Anand, V. (1999). Recombinant adenovirus and ocular gene therapy. International Retinitis Pigmentosa Association, http://www.irpa.org/sci-news/top-benne.htm.
14. Hoffman, L. M., Maguire, A. M., and Bennett, J. (1997). Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest. Ophthalmol. Vis. Sci. 38: 2224-2233.
15. Borras, T., Tamm, E. R., and Zigler, J. S., Jr. (1996). Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest. Ophthalmol. Vis. Sci. 37: 1282-1293.
16. Tsubota, K., et al. (1998). Adenovirus-mediated gene transfer to the ocular surface epithelium. Exp. Eye Res. 67: 531-538.
17. Larkin, D. F., Oral, H. B., Ring, C. J., Lemoine, R., and George, A. J. (1996). Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 61: 363-370.
18. Oral, H. B., et al. (1997). Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther. 4: 639-647.
19. Epstein, D., Allingham, R., and Schuman, J. (1997). Chandler and Grant's Glaucoma. Williams and Wilkins, Baltimore, MD.
20. Di Polo, A., Aigner, L. J., Dunn, R. J., Bray, G. M., and Aguayo, A. J. (1998). Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc. Natl. Acad. Sci. USA 95: 3978-3983.
21. Dudus, L., et al. (1999). Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vis. Res. 39: 2545-2554.
22. Simon, P., et al. (1999). Bcl-2 gene therapy exacerbates excitotoxicity. Hum. Gene Ther. 10: 1715-1720.
23. Vorwerk, C. K., et al. (2000). In vivo gene therapy with AAV-bFGF protects against excitotoxicity. Invest. Ophthalmol. Vis. Sci.: in press.
24. Kaplan, J., Bonneau, D., Frezal, J., Munnich, A., and Dufier, J. L. (1990). Clinical and genetic heterogeneity in retinitis pigmentosa. Hum. Genet. 85: 635-642.
25. Hauswirth, W. W., and Mclnnes, R. R. (1998). Retinal Gene Therapy Workshop Summary 1998. World Wide Web (http://www.molvis.org/molvis/v4/all/).
26. McLaughlin, M. E., Sandberg, M. A., Berson, E. L., and Dryja, T. P. (1993). Recessive mutations in the gene encoding the beta subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat. Genet. 4: 130-134.
27. Pittler, S. J., and Baehr, W. (1991). Identification of a nonsense mutation in the rod photoreceptor cGMP-phosphodiesterase beta subunit gene of the rd mouse. Proc. Natl. Acad. Sci. USA 88: 8322-8326.
28. Suber, M. L., et al. (1993). Irish setter dogs affected with rod/cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase b-subunit gene. Proc. Natl. Acad. Sci. USA 90: 3968-3972.
29. Lem, J., et al. (1992). Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase and β subunit. Proc. Natl. Acad. Sci. USA 89: 4422-4426.
30. Bennett, J., et al. (1996). Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat. Med. 2: 649-654.
31. Jomary, C., Vincent, K., Grist, J., Neal, M., and Jones, S. (1997). Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther. 4: 683-690.
32. Bennett, J., Anand, V., Acland, G. M., and Maguire, A. M. (2000). Cross-species comparison of in vivo reporter gene expression after rAAV-mediated retinal transduction. Methods Enzymol.: in press.
33. Kumar-Singh, R., and Farber, D. (1998). Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: Application to the rescue of photoreceptor degeneration. Hum. Mol. Genet. 7: 1893-1900.
34. Takahashi, M., Miyoshi, H., Verma, I. M., and Gage, F. H. (1999). Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73: 7812-7816.
35. Sung, C.-H., Schneider, B. G., Papermaster, D., and Nathans, J. (1991). Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88: 8840-8844.
36. Kaushal, S., and Khorana, H. (1994). Structure and function in rhodopsin. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33: 6121-6128.
37. Sullenger, B., and Cech, T. (1994). Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 371: 619.
38. Lewin, A. S., et al. (1998). Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. 4: 967-971.
39. Adler, R. (1996). Mechanisms of photoreceptor death in retinal degenerations. Arch. Ophthalmol. 114: 79-83.
40. Portera-Cailliau, C., Sung, C.-H., Nathans, J., and Adler, R. (1994). Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 91: 974-978.
41. Tso, M. O. M., et al. (1994). Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. Invest. Ophthalmol. Vis. Sci. 36: 2693-2699.
42. Chang, G.-Q., Hao, Y., and Wong, F. (1993). Apoptosis: Final common pathway of photoreceptor death in rd, rds and rhodopsin mutant mice. Neuron 11: 595-605.
43. Lolley, I. R. N., Rong, H., and Craft, C. M. (1994). Linkage of photoreceptor degeneration by apoptosis with inherited defect in phototransduction. Invest. Ophthalmol. Vis. Sci. 35: 358-362.
44. Korsmeyer, S. J., Shutter, J. R., Yeis, D. J., Merry, D. E., and Oltvai, Z. N. (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4: 327-332.
45. Chen, J., et al. (1996). bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc. Natl. Acad. Sci. USA 93: 7042-7047.
46. Zeng, Y., et al. (1997). Genomic and somatic delivery of rhodopsin-promoted bcl-2 results in a mild delay in photoreceptor cell death in the rd/rd mouse. Invest. Ophthalmol. Vis. Sci. 38: S1133.
47. Bennett, J., et al. (1998). Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse. Gene Ther. 5: 1156-1164.
48. Cayouette, M., and Gravel, C. (1997). Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum. Gene Ther. 8: 423-430.
49. Cayouette, M., Behn, D., Sendtner, M., Lachapelle, P., and Gravel, C. (1998). Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J. Neurosci. 18: 9282-9293.
50. Akimoto, M., et al. (1999). Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest. Ophthalmol. Vis. Sci. 40: 273-279.
51. McGee, L. H., et al. (1999). Rescue of photoreceptor degeneration in S334ter(4) mutant rhodopsin transgenic rats by adeno-associated virus (AAV)-mediated delivery of basic fibroblast growth factor. Invest. Ophthalmol. Vis. Sci. 40: S936.
52. Utteza, Y., et al. (1999). Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc. Natl. Acad. Sci. USA 96: 3126-3131.
53. Kimura, H., et al. (1996). Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: Feasibility in prevention of proliferative vitreoretinopathy. Hum. Gene Ther. 7: 799-808.
54. Murata, T., et al. (1997). Ocular gene therapy: Experimental studies and clinical possibilities. Ophthalmol. Res. 29: 242-251.
55. Hurwitz, R., Brenner, M., Poplack, D., and Horowitz, M. (1999). Retinoblastoma treatment. Science 284: 2066.